Journal ArticleDOI
Cancer associated fibroblasts tailored tumor microenvironment of therapy resistance in gastrointestinal cancers.
Reads0
Chats0
TLDR
Predictably, targeting therapy‐resistant CAFs is a promising adjunctive treatment to benefit GI patients and some key problems about distinguishing CAFs subpopulations and controversial issues on pleiotropic CAFs in medication need to be solved for subsequent clinical application.Abstract:
Gastrointestinal cancers (GI), are a group of highly aggressive malignancies with heavy cancer-related mortalities. Even if continued development of therapy methods, therapy resistance has been a great obstruction for cancer treatment and thereby inevitably leads to depressed final mortality. Peritumoral cancer associated fibroblasts (CAFs), a versatile population assisting cancer cells to build a facilitated tumor microenvironment (TME), has been demonstrated exerting a promotion influence on cancer proliferation, migration, invasion, metastasis, and also therapy resistance. In this review, we provide an update progress in describing how CAFs mediate therapy resistance in GI by various means, meanwhile highlight the crosstalk between CAFs and cancer cells and present some vital signaling pathways activated by CAFs in this resistant process. Furthermore, we discuss the current advances in adopting novel drugs against CAFs and how the knowledge contributing to improved therapy efficacy in clinical practice. In sum, CAFs create a therapy-resistant TME in several aspects of GI progression, although some key problems about distinguishing CAFs subpopulations and controversial issues on pleiotropic CAFs in medication need to be solved for subsequent clinical application. Predictably, targeting therapy-resistant CAFs is a promising adjunctive treatment to benefit GI patients.read more
Citations
More filters
Journal ArticleDOI
Cancer immunotherapy: Pros, cons and beyond.
Shuzhen Tan,Dongpei Li,Xiao Zhu +2 more
TL;DR: An overview of recent developments in immunotherapy is given and a new direction of tumor treatment is indicated through analyzing the pros and cons of immunotherapy coupled with keeping a close watch on the development trend of the immunotherapy future.
Journal ArticleDOI
JNK signaling in cancer cell survival.
Qinghua Wu,Qinghua Wu,Qinghua Wu,Wenda Wu,Wenda Wu,Bishi Fu,Lei Shi,Xu Wang,Kamil Kuca,Kamil Kuca +9 more
TL;DR: Recent advances in understanding the prosurvival function of JNK and its role in tumor development and chemoresistance are highlighted, including a comprehensive analysis of the molecular mechanisms underlying JNK‐mediated cancer cell survival.
Journal ArticleDOI
Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer
Fanglong Wu,Jin Yang,Junjiang Liu,Ye Wang,Jingtian Mu,Qingxiang Zeng,Shuzhi Deng,Hongmei Zhou +7 more
TL;DR: In this paper, a comprehensive understanding of these signaling cascades in interactions between cancer cells and CAFs is necessary to fully realize the pivotal roles of CAFs in cancers, and three potential targeting strategies, including, epithelial-mesenchymal common targets, sequential target perturbation, and crosstalk-directed signaling targets, paving the way for CAF-directed or host cell-directed antitumor therapy.
Journal ArticleDOI
The roles of glucose metabolic reprogramming in chemo- and radio-resistance.
Jinguan Lin,Longzheng Xia,Jiaxin Liang,Yaqian Han,Heran Wang,Linda Oyang,Shiming Tan,Yutong Tian,Shan Rao,Xiao Yan Chen,Yanyan Tang,Min Su,Xia Luo,Ying Wang,Hui Wang,Yujuan Zhou,Qianjin Liao +16 more
TL;DR: This review summarizes recent progress in the understanding of glucose metabolism in chemo- and radio-resistance malignancy, and highlights potential molecular targets and their inhibitors for cancer treatment.
Journal ArticleDOI
Exosomal miRNAs in tumor microenvironment
Shiming Tan,Longzheng Xia,Pin Yi,Pin Yi,Yaqian Han,Lu Tang,Lu Tang,Qing Pan,Qing Pan,Yutong Tian,Yutong Tian,Shan Rao,Linda Oyang,Jiaxin Liang,Jinguan Lin,Min Su,Yingrui Shi,Deliang Cao,Deliang Cao,Yujuan Zhou,Qianjin Liao +20 more
TL;DR: The role of exosomal miRNAs in the process of TME reshaping is updated, creating a microenvironment that is conducive to tumor growth, metastasis, immune escape and chemotherapy resistance.
References
More filters
Journal ArticleDOI
The biology and function of fibroblasts in cancer
TL;DR: Cancer-associated fibroblasts (CAFs) become synthetic machines that produce many different tumour components and have a role in creating extracellular matrix structure and metabolic and immune reprogramming of the tumour microenvironment with an impact on adaptive resistance to chemotherapy.
Journal ArticleDOI
Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival.
Berna C. Özdemir,Berna C. Özdemir,Tsvetelina Pentcheva-Hoang,Julienne L. Carstens,Xiaofeng Zheng,Chia Chin Wu,Tyler R. Simpson,Hanane Laklai,Hikaru Sugimoto,Hikaru Sugimoto,Christoph Kahlert,Christoph Kahlert,Sergey V. Novitskiy,Ana De Jesus-Acosta,Padmanee Sharma,Pedram Heidari,Umar Mahmood,Lynda Chin,Harold L. Moses,Valerie M. Weaver,Anirban Maitra,James P. Allison,Valerie S. LeBleu,Valerie S. LeBleu,Raghu Kalluri,Raghu Kalluri +25 more
TL;DR: Although myofibroblast-depleted tumors did not respond to gemcitabine, anti-CTLA4 immunotherapy reversed disease acceleration and prolonged animal survival, and underscores the need for caution in targeting carcinoma-associated fibroblasts in PDAC.
Journal ArticleDOI
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
TL;DR: In this paper, the authors discuss the link between the epithelial-to-mesenchymal transition (EMT) and the cancer stem cell (CSC) phenotype and discuss how this knowledge can contribute to improvements in clinical practice.
Journal ArticleDOI
Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma
Andrew D. Rhim,Andrew D. Rhim,Paul E. Oberstein,Dafydd H. Thomas,Emily T. Mirek,Carmine F. Palermo,Stephen A. Sastra,Erin N. Dekleva,Tyler Saunders,Claudia P. Becerra,Ian W. Tattersall,C. Benedikt Westphalen,Jan Kitajewski,Maite G. Fernandez-Barrena,Martin E. Fernandez-Zapico,Christine A. Iacobuzio-Donahue,Kenneth P. Olive,Ben Z. Stanger +17 more
TL;DR: De deleting Shh in a well-defined mouse model of PDAC demonstrated that some components of the tumor stroma can act to restrain tumor growth, and administration of VEGFR blocking antibody selectively improved survival of Shh-deficient tumors.
Journal ArticleDOI
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
Ravid Straussman,Teppei Morikawa,Kevin Shee,Michal Barzily-Rokni,Zhi Rong Qian,Jinyan Du,Ashli Davis,Margaret M. Mongare,Joshua Gould,Dennie T. Frederick,Zachary A. Cooper,Paul B. Chapman,David B. Solit,Antoni Ribas,Roger S. Lo,Keith T. Flaherty,Shuji Ogino,Jennifer A. Wargo,Todd R. Golub +18 more
TL;DR: It is found that stroma-mediated resistance is common, particularly to targeted agents, and the systematic dissection of interactions between tumours and their micro-environment can uncover important mechanisms underlying drug resistance.